A Study of Chlorambucil Plus MabThera as Induction Therapy Followed in Responders by Maintenance Therapy Versus Observation on Response Rate in Patients greater than or equal to 60 Years With Previously Untreated Chronic Lymphocytic Leukemia.
Phase of Trial: Phase II
Latest Information Update: 17 Aug 2017
At a glance
- Drugs Rituximab (Primary) ; Chlorambucil
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- Sponsors Roche
- 31 Aug 2018 Biomarkers information updated
- 23 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 13 May 2013 Planned end date changed from 1 May 2013 to 1 Jun 2013 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History